A biopharma accelerator programme that aggregates the best Oxford single asset small molecule programmes under one roof. Partners include OUI, Evotec and Bristol Myers Squibb (BMS).
Member count: 11-50
Investors 1
| Date | Name | Website |
| - | Oxford Sci... | oxfordscie... |